Influence of cisplatinum and 5-fluorouracil on the oral mucosa

Platz, 1988, Einführung in die “Prospektive DÖSAK-Studie über Plattenepithelkarzinome der Lippen, der Mundhöhle und des Oropharynx”, Dtsch Z Mund Kiefer GesichtsChir, 12, 293 1992 Day, 1992, Second primary tumours in patients with oral cancer, Cancer, 70, 14, 10.1002/1097-0142(19920701)70:1<14::AID-CNCR2820700103>3.0.CO;2-S Vries de, 1990, Magnitude of the problem Krifka, 1992, Vergleichende Untersuchung zweier Patientengruppen mit primären Mund-höhlenkarzinomen aus dem Zeitraum 1981 bis 1989, 40 Grässel-Pietrusky, 1982, Histologische Klassifikation oraler Präkanzerosen, Dtsch Z Mund Kiefer GesichtsChir, 6, 343 Hemmer, 1990, Flow cytometric DNA ploidy analysis of squamous cell carcinoma of the oral cavity, Cancer, 66, 317, 10.1002/1097-0142(19900715)66:2<317::AID-CNCR2820660220>3.0.CO;2-X Ploton, 1986, Improvement in the staining and in the visualisation of the argyrophilic proteins of the nucleolar organiser region at the optical level, Histochem J, 18, 5, 10.1007/BF01676192 Crocker, 1989, How should we count AgNORs? Proposals for a standardised approach, J Pathol, 158, 185, 10.1002/path.1711580303 Hsu, 1981, Protein A avidin and biotin in immunohistochemistry, J Histochem Cytochem, 29, 1349, 10.1177/29.11.6172466 Zöller J, Flentje M, Herrmann A, Sinn P, Born IA. Evaluation of AgNOR and Ki-67 antigen as cell kinetic parameters in oral dysplasias and carcinomas. An Cell Pathol (in press). Gerdes, 1984, Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67, J Immunol, 133, 1710, 10.4049/jimmunol.133.4.1710 Moll, 1986, Epitheliale tumour marker, Verh Dtsch Ges Path, 70, 28 Cintorino, 1990, Topography-related expression of individual cytokeratons in normal and pathological (non-neoplastic and neoplastic) human oral mucosa, Virchows Archiv A, 417, 419, 10.1007/BF01606030 Slaughter, 1953, Field cancerisation in oral stratified epithelium: clinical implications of multicentric origin, Cancer, 6, 963, 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q Stell, 1990, A phase III randomized trial of cisplatinum, methotrexate, cisplatinum+methotrexate and cisplatinum + 5FU in end stage squamous cell carcinoma of the head and neck, Br J Cancer, 61, 311, 10.1038/bjc.1990.59 Schröder, 1986, Einfluβ der Chemotherapie auf die Überlebenszeit von Patienten mit weit fortgeschrittenen Plattenepithel-Karzinomen des Kopf-Hals-Bereiches, Laryng Rhinol Otol, 65, 11, 10.1055/s-2007-998770 Taylor, 1984, A randomized trial of adjuvant chemotherapy in head and neck squamous cancer Bodemann, 1986, Neoadjuvante chemotherapie bei kpft-hals-tumoren, Dtsch Med Wschr, 11, 1097, 10.1055/s-2008-1068589 Hong, 1984, Adjuvant chemotherapy as initial treatment of advanced head and neck cancer. Survival data at three years Bruntsch, 1985, Primäre chemotherapie fortgeschrittener plattenepithelkarzinome im kopf-hals-bereich, Dtsch Med Wochenschr, 110, 1889, 10.1055/s-2008-1069108 Neugut, 1992, Multiple primary neoplasms, Cancer J, 5, 245